本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Redhill Biopharma Ltd

1.98
+0.06623.46%
盤後1.990.0100+0.51%18:45 EDT
成交量:4.02萬
成交額:7.84萬
市值:346.90萬
市盈率:-0.30
高:2.03
開:1.89
低:1.85
收:1.91
資料載入中...
2020/04/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/04

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals